Happify health and Almirall go live with digital solution to support psoriasis patients by Tracy Williams June 16, 2022 June 16, 2022 579 Today, Happify Health, the Intelligent Healing Company™, and Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on skin health, announced that Claro, a digital program developed via the innovative partnership of both companies, is live and now available to people with psoriasis in Spain, Italy and the United Kingdom. Claro was built to improve the mental well-being of people with psoriasis through cognitive behavioral therapy, positive psychology, and mindfulness. Psoriasis is one of the world’s most prevalent skin diseases, affecting about 60 million people worldwide2. A 2019 study in Maedica, a Journal of Clinical Medicine, establishes a clear link between skin psychology and quality of life for people with psoriasis4. It is estimated that 20% to 30% of people, globally, with moderate to severe psoriasis also suffer from mental health issues, like anxiety and depression1. Approximately 80% of those affected with psoriasis have mild to moderate symptoms, with direct healthcare costs for treatment of psoriasis exceeding $65 billion annually3. “At Almirall, we are proud to offer psoriasis patients a wide range of medicines that cover the whole spectrum of the disease, from mild to severe. Claro helps us to fulfill our commitment to people living with psoriasis, providing them with an enhanced solution addressed to their wellbeing, so they can get their lives back,” said Dr. Volker Koscielny, MD, Chief Medical Officer of Almirall. “Psoriasis is a significant burden in the daily life of 71% of people who suffer from it, according to the National Psoriasis Foundation in the U.K.3,” said Theo Ahadome, Senior Vice President of Commercialization at Happify Health. “We are very pleased with the level of engagement we are seeing so far among Claro users, and this partnership gives us the opportunity to study how effective digital programs are at keeping psoriasis patients engaged during treatment for psoriasis and improving their quality of life.” Almirall S.A.Happify Health Share 0 FacebookTwitterPinterestEmail Tracy Williams previous post Tipping point’ reached as public say they prefer health apps to antidepressants to support mental health conditions next post Dementia Management Tool “Vera” Launches on Apple’s AppStore You may also like Challenges facing the custom orthotic design industry July 4, 2024 VivaTech 2024: German Bionic to showcase 360° human augmentation in Paris May 3, 2024 6 Autism stereotypes we need to overcome May 2, 2024 April 24, 2024 Public concern about the NHS soars as delays accessing A&E and GP... April 23, 2024 Spoken Announces Update and Plans for Autism Acceptance Month April 22, 2024 A third of Brits have difficulty accessing their GP. Local health reforms... April 19, 2024 Transform Healthcare Unveils 10-Point Transformation Plan Under New Leadership April 18, 2024 Coventry University leads UK-Indonesia initiative to increase disability inclusion in higher education April 17, 2024 PhD student aims to help save lives as autism research is included... April 16, 2024 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.